Envista

Acatechol, Inc.

Other

Catacore, Inc.

Sam Linh Nguyen

Byung Jun Ahn

Bruce H Lipshutz

Roscoe Linstadt

In one embodiment, the present application discloses a surface binding compound of the Formula I or Formula II: wherein the variables EG, EG1, SP1, SP2, SP3, Ar and BG are as defined herein. In another embodiment, the application discloses a method for forming a coating on a surface of a substrate using the surface binding compound of the Formula I or Formula II.

Surface primer compositions and methods of use

In one embodiment, the present application discloses a photo-cleavable surface binding compound of the Formula I and Formula II: wherein the variables EG, EG1, SP1, SP2, SP3, Ar and BG are as defined herein. In another embodiment, the application discloses a method for forming a coating on a surface of a substrate using the surface binding compound.

Photo-cleavable primer compositions and methods of use

The present application discloses an adhesive composition comprising a polymer of the formulae A, B and C: and methods for using the adhesive composition. 

Ionic polymers and their use as wet-adhesives and coatings

The present application discloses an adhesive composition comprising a polymer of the formulae A, B and C and methods for using the adhesive composition.

In one embodiment, the present application discloses an aqueous ophthalmic composition for the treatment of eye diseases, lesions and injuries, comprising: a) one steroid, or a combination of at least two steroids selected from the group consisting of lanosterol, dihydrolanosterol, 4,4-dimethylcholesta-8(9),14,24-trien-3&#x3b2;-ol, 4,4-dimethylcholesta-8,24-dien-3&#x3b2;-ol, 4,4-dimethylcholesta-8-en-3&#x3b2;-ol, 4,4-dimethylcholesta-8(9),14-dien-3&#x3b2;-ol, 14-desmethyl lanosterol, lathosterol, &#x394;-cholestadienol, cholesterol, cholesta-7-enol, cholesteryl ester, 7-dehydrocholesterol, desmosterol, 7-dehydrodesmosterol, zymosterol, 27-hydroxycholesterol, cholesta-7,24-dien-3-&#x3b2;-ol, cholesta-8(9)-en-3-&#x3b2;-ol, 5&#x3b1;-cholestan-3&#x3b2;-ol-6-one, 5-cholesten-3&#x3b2;,25-diol, 5-cholesten-3&#x3b2;,25-OSOH (5-cholesten-3&#x3b2;,25-sulfate), 5-cholesten-3&#x3b2;-OSOH,25-ol (5-cholesten-3&#x3b2;-sulfate,25-ol), 5-cholesten-3&#x3b2;,25-diol, disulfate, and their esters thereof, or a pharmaceutically acceptable salt thereof, in a concentration effective for the treatment and/or prophylaxis of the eye diseases, lesions and injuries; and b) a pharmaceutical excipient; and methods of treatment using such compositions.

Growing community of inventors

Saratoga, CA, United States of America

Sam Linh Nguyen